Kolexia
Huillard Olivier Oncologie médicale
Huillard Olivier
Oncologie médicale
Hôpital Cochin
Paris, France
178 Activités
437 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Tumeurs de la prostate Tumeurs de la thyroïde Tumeurs du rein Sarcopénie Tumeurs prostatiques résistantes à la castration Tumeurs du poumon Tumeurs de la vessie urinaire

Collaborateurs

Voir plus
Goldwasser Francois
Goldwasser Francois
Hôpital Cochin, Paris, France
Alexandre Jerome
Alexandre Jerome
Cabinet libéral, Paris, France
Boudou-Rouquette Pascaline
Boudou-Rouquette Pascaline
Hôpital Cochin, Paris, France
Arrondeau Jennifer
Arrondeau Jennifer
Hôpital Cochin, Paris, France

Industries

Voir plus
BMS
11 collaboration(s)
Dernière en 2023
Ipsen
9 collaboration(s)
Dernière en 2023
Advanced Accelerator Applications
6 collaboration(s)
Dernière en 2023
MSD
6 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Bilan diagnostique des toxicités cutanées et unguéales ... - Facebook
Facebook   10 mars 2024
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley): A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination With Other AntiTumor Agents as a Maintenance Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress With First Line Platinum-Containing Chemotherapy (JAVELIN Bladder Medley)
Essai Clinique (Emd Serono)   05 février 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
British journal of cancer   25 janvier 2024
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
JAMA oncology   26 octobre 2023
Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer.
Thyroid : official journal of the American Thyroid Association   12 octobre 2023
2364MO Durvalumab (D) +/- tremelimumab (T) in combination with dose-dense MVAC (ddMVAC) as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma (MIBC): Results of NEMIO, a randomized phase I-II trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
2373P Outcomes by retrospective eligibility for maintenance therapy of patients (pts) with advanced urothelial carcinoma (UC): Post hoc analysis of KEYNOTE-361
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease.
Cancer treatment and research communications   08 septembre 2023
Polyploid Giant Cancer Cells Are Frequently Found in the Urine of Prostate Cancer Patients.
Cancers   27 juin 2023
ANGIOCOR: Predictive Role of Circulating Biomarkers Involved in Angiogenesis in Metastatic Kidney Cancer in the Era of New Therapeutic Associations: Immunotherapies, Anti-angiogenic
Essai Clinique (Assistance publique – Hôpitaux de Paris)   14 avril 2023